Clinical Trials Directory

Trials / Unknown

UnknownNCT03156894

Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Among the complications of heart transplant, primary dysfunction of the graft (PDG) is the most feared with a net impact on early morbidity and mortality. The all-cause mortality rate at the international level is 10% at 30 days and 34% at one year. Mortality at 30 days is secondary in 66% of cases with DPG or multi-organ failure. The treatment of choice for the more severe PDG remains ECMO-type circulatory mechanical assistance or ventricular assistance. According to several studies, this could reduce early mortality. Early placement and short-term (\<30 days) of support appear to improve survival in the first year after transplantation. The haemodynamic parameters revealing this DPG are not clearly described in the literature. hypothesis of this research is that: * DPG risk factors in strasbourg's hospital center are comparable to other European and international centers. * Simple hemodynamic parameters can be used to detect PDG earlier in order to set up assistance more quickly.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2017-05-17
Last updated
2018-01-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03156894. Inclusion in this directory is not an endorsement.